StockData
Jaguar Health, Inc. logo

Jaguar Health, Inc. (JAGX) stock

JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$0.39−0.03 (-7.14%)

Close on Nov 16, 2026Market cap $2.02MP/E –Yield –

Jaguar Health cash

Cash and short-term investments held at the end of each period.

Jaguar Health's cash was $3.79M at Jun 30, 2026. For fiscal 2025 it was $968.00K, down 87.9% from the year before. Over ten years it grew -18.7% a year on average. The highest annual figure on record is $17.05M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$968.00K-87.9%
FY2024Dec 31, 2024$8.00M+23.7%
FY2023Dec 31, 2023$6.47M+18.3%
FY2022Dec 31, 2022$5.47M-67.9%
FY2021Dec 31, 2021$17.05M+110.8%
FY2020Dec 31, 2020$8.09M+108.3%
FY2019Dec 31, 2019$3.88M+51.2%
FY2018Dec 31, 2018$2.57M+238.0%
FY2017Dec 31, 2017$759.87K-48.0%
FY2016Dec 31, 2016$1.46M-81.0%
FY2015Dec 31, 2015$7.70M+810.7%
FY2014Dec 31, 2014$845.19K+356.0%
FY2013Dec 31, 2013$185.37K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$3.79M+71.6%
Q1 FY2026Mar 31, 2026$7.28M+27.9%
Q4 FY2025Dec 31, 2025$968.00K-87.9%
Q3 FY2025Sep 30, 2025$3.53M-73.4%
Q2 FY2025Jun 30, 2025$2.21M-86.2%
Q1 FY2025Mar 31, 2025$5.69M-51.2%
Q4 FY2024Dec 31, 2024$8.00M+23.7%
Q3 FY2024Sep 30, 2024$13.27M+311.3%
Q2 FY2024Jun 30, 2024$16.05M+86.0%
Q1 FY2024Mar 31, 2024$11.67M-18.8%
Q4 FY2023Dec 31, 2023$6.47M+18.3%
Q3 FY2023Sep 30, 2023$3.23M-69.5%
Q2 FY2023Jun 30, 2023$8.63M-4.3%
Q1 FY2023Mar 31, 2023$14.37M-17.7%
Q4 FY2022Dec 31, 2022$5.47M-67.9%
Q3 FY2022Sep 30, 2022$10.56M-14.7%
Q2 FY2022Jun 30, 2022$9.01M-71.8%
Q1 FY2022Mar 31, 2022$17.46M-45.9%
Q4 FY2021Dec 31, 2021$17.05M+110.8%
Q3 FY2021Sep 30, 2021$12.38M+817.3%
Q2 FY2021Jun 30, 2021$31.91M+958.4%
Q1 FY2021Mar 31, 2021$32.25M+2554.3%
Q4 FY2020Dec 31, 2020$8.09M+108.3%
Q3 FY2020Sep 30, 2020$1.35M-34.8%
Q2 FY2020Jun 30, 2020$3.02M+87.6%
Q1 FY2020Mar 31, 2020$1.22M-52.8%
Q4 FY2019Dec 31, 2019$3.88M+51.2%
Q3 FY2019Sep 30, 2019$2.07M+185.1%
Q2 FY2019Jun 30, 2019$1.61M-33.4%
Q1 FY2019Mar 31, 2019$2.57M+238.5%
Q4 FY2018Dec 31, 2018$2.57M+1064.2%
Q3 FY2018Sep 30, 2018$726.13K-73.7%
Q2 FY2018Jun 30, 2018$2.41M+100.1%
Q4 FY2017Dec 31, 2017$759.87K-48.0%
Q3 FY2017Sep 30, 2017$220.59K-87.8%
Q2 FY2017Jun 30, 2017$2.76M-28.8%
Q1 FY2017Mar 31, 2017$1.21M–
Q4 FY2016Dec 31, 2016$1.46M–
Q3 FY2016Sep 30, 2016$1.81M–
Q2 FY2016Jun 30, 2016$3.88M–

More Jaguar Health figures

See a number that looks wrong?